- Home
- FNF vs ICLR Comparison
FNF vs ICLR Comparison
Compare FNF & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNF
- ICLR
- Stock Information
- Founded
- FNF 1847
- ICLR 1990
- Country
- FNF United States
- ICLR Ireland
- Employees
- FNF N/A
- ICLR N/A
- Industry
- FNF Specialty Insurers
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FNF Finance
- ICLR Health Care
- Exchange
- FNF Nasdaq
- ICLR Nasdaq
- Market Cap
- FNF 16.0B
- ICLR 14.3B
- IPO Year
- FNF N/A
- ICLR 1998
- Fundamental
- Price
- FNF $56.58
- ICLR $192.95
- Analyst Decision
- FNF Strong Buy
- ICLR Buy
- Analyst Count
- FNF 5
- ICLR 15
- Target Price
- FNF $71.00
- ICLR $210.64
- AVG Volume (30 Days)
- FNF 939.3K
- ICLR 955.9K
- Earning Date
- FNF 11-05-2025
- ICLR 10-22-2025
- Dividend Yield
- FNF 3.54%
- ICLR N/A
- EPS Growth
- FNF 16.93
- ICLR 13.11
- EPS
- FNF 3.93
- ICLR 9.73
- Revenue
- FNF $13,634,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- FNF $1.15
- ICLR N/A
- Revenue Next Year
- FNF $10.81
- ICLR $1.68
- P/E Ratio
- FNF $14.36
- ICLR $19.85
- Revenue Growth
- FNF 7.26
- ICLR N/A
- 52 Week Low
- FNF $50.61
- ICLR $125.10
- 52 Week High
- FNF $66.72
- ICLR $289.29
- Technical
- Relative Strength Index (RSI)
- FNF 44.96
- ICLR 61.79
- Support Level
- FNF $54.60
- ICLR $184.24
- Resistance Level
- FNF $57.09
- ICLR $198.30
- Average True Range (ATR)
- FNF 1.15
- ICLR 6.47
- MACD
- FNF -0.03
- ICLR 0.33
- Stochastic Oscillator
- FNF 35.44
- ICLR 69.81
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.